@BusinessDaily

Johnson & Johnson litigation takes new focus with asbestos

6 months ago, 16 Apr 08:50

By: Reuters

A $117 million (Sh17.8 billion) verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J’s Baby Powder could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said. J&J has been battling some 6,000 cases claiming its baby powder and Shower to Shower products cause ovarian cancer. The $117 million verdict by a New Jersey jury last week, however, involved a different form of cancer that is clearly linked to asbestos. Plaintiffs lawyers claim that internal J&J documents seen in that trial show that baby powder had been contaminated with asbestos. They now plan to use the documents in upcoming ovarian cancer trials to allege that the asbestos contamination also caused that form of cancer. J&J and Imerys Talc America, a unit of Imerys SA, have vowed to appeal the New Jersey verdict and deny asbestos has ever been present in their products or that their talc can cause any form of cancer. The case of Stephen Lanzo, a New Jersey resident who claimed he developed mesothelioma after using baby powder since his birth in 1972, was the first time a jury saw the internal J&J documents which plaintiffs claim show that J&J knew since the 1970s that the talc in its baby powder was contaminated by asbestos during the mining process. J&J says the documents present no such evidence, but merely show the company’s caution. Peter Bicks, a lawyer leading J&J’s talc asbestos defense, said that in the early 1970s, the company was looking at how it could potentially remove asbestos from talc if the two became intermingled in the mining process. He says no contamination was ever found, citing decades of testing by independent laboratories and scientists. Bicks called the claims of a link between talc and asbestos “junk science.” Mesothelioma, a rare and deadly form of cancer closely associated with exposure to asbestos, affects the delicate tissue that lines body cavities. While the link between asbestos and mesothelioma is sufficiently established, scientists are divided on whether asbestos exposure can cause ovarian cancer. Some studies have shown an association between the two, while other studies have found no such link. Elizabeth Burch, holder of the Charles H. Kirbo Chair of Law at the University of Georgia, said it remained an open question whether talc contained asbestos and that each case would turn on the facts. But J&J, which had $76.5 billion (in sales in 2017, gives the plaintiffs’ bar an enticing new target, said Nathan Schachtman, a lecturer at Columbia University who used to defend asbestos cases. Some 3,000 people are diagnosed with mesothelioma each year, according to the American Cancer Society, a number that Howard Erichson, a law professor at Fordham University who specializes in mass tort litigation, called significant from a legal standpoint. But the roughly 22,000 women who were diagnosed with ovarian cancer last year, according to the National Cancer ...
Read More


Category: business news corporate lifestyle economy markets opinion

Suggested

13 hours ago, 16:59
@BusinessDaily - By: James Ngunjiri
Medical claims raise payout by Sh1bn

Claims in the medical, motor private and motor commercial segments of general insurance rose nearly Sh1 billion to raise overall claims insurers incurred 2.03 per cent during the second quarter. ...

Category: business news
12 hours ago, 18:14
@BusinessDaily - By: Lynet Igadwah
Uhuru, Ruto foreign travel spend falls 69pc

President Uhuru Kenyatta and his deputy William Ruto cut their foreign travel expenditure by 69 per cent or Sh223.3 million in the year to June as pressure piles on top government officials to ...

Category: business economy news
12 hours ago, 17:53
@BusinessDaily - By: Patrick Alushula
Kenya Power drops after profit warning

Kenya Power’s share plunged by 7.95 per cent in Monday’s trading at the Nairobi Securities Exchange (NSE) to close at Sh4.05 as investors factored in a profit warning. ...

Category: business economy news
12 hours ago, 17:56
@BusinessDaily - By: Constant Munda
Ngong wind firm gets Sh23.5bn loans insurance guarantee

Developers of the 100-megawatt Kipeto Wind Power Farm will tap emergency funds from African Trade Insurance Agency (ATI) to service a Sh23.53 billion loan. ...

Category: business economy news
12 hours ago, 17:45
@BusinessDaily - By: Doreen Wainainah
Airtel, Telkom join Safaricom with excise tax on mobile fees

Telco firms Airtel and Telkom Kenya have raised their call and messaging rates by 30 cents and 10 cents respectively. ...

Category: business economy news
12 hours ago, 17:47
@BusinessDaily - By: Doreen Wainainah
Hoteliers mourn deaths of Sarova founder, family

Kenyan hoteliers and the Vohra family were Monday still coming to terms with the tragic loss of Mohinder Singh Vohra (MS) and four family members in a road accident. ...

Category: business markets news corporate

@BusinessDaily

Johnson & Johnson litigation takes new focus with asbestos

6 months ago, 16 Apr 08:50

By: Reuters
A $117 million (Sh17.8 billion) verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J’s Baby Powder could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said. J&J has been battling some 6,000 cases claiming its baby powder and Shower to Shower products cause ovarian cancer. The $117 million verdict by a New Jersey jury last week, however, involved a different form of cancer that is clearly linked to asbestos. Plaintiffs lawyers claim that internal J&J documents seen in that trial show that baby powder had been contaminated with asbestos. They now plan to use the documents in upcoming ovarian cancer trials to allege that the asbestos contamination also caused that form of cancer. J&J and Imerys Talc America, a unit of Imerys SA, have vowed to appeal the New Jersey verdict and deny asbestos has ever been present in their products or that their talc can cause any form of cancer. The case of Stephen Lanzo, a New Jersey resident who claimed he developed mesothelioma after using baby powder since his birth in 1972, was the first time a jury saw the internal J&J documents which plaintiffs claim show that J&J knew since the 1970s that the talc in its baby powder was contaminated by asbestos during the mining process. J&J says the documents present no such evidence, but merely show the company’s caution. Peter Bicks, a lawyer leading J&J’s talc asbestos defense, said that in the early 1970s, the company was looking at how it could potentially remove asbestos from talc if the two became intermingled in the mining process. He says no contamination was ever found, citing decades of testing by independent laboratories and scientists. Bicks called the claims of a link between talc and asbestos “junk science.” Mesothelioma, a rare and deadly form of cancer closely associated with exposure to asbestos, affects the delicate tissue that lines body cavities. While the link between asbestos and mesothelioma is sufficiently established, scientists are divided on whether asbestos exposure can cause ovarian cancer. Some studies have shown an association between the two, while other studies have found no such link. Elizabeth Burch, holder of the Charles H. Kirbo Chair of Law at the University of Georgia, said it remained an open question whether talc contained asbestos and that each case would turn on the facts. But J&J, which had $76.5 billion (in sales in 2017, gives the plaintiffs’ bar an enticing new target, said Nathan Schachtman, a lecturer at Columbia University who used to defend asbestos cases. Some 3,000 people are diagnosed with mesothelioma each year, according to the American Cancer Society, a number that Howard Erichson, a law professor at Fordham University who specializes in mass tort litigation, called significant from a legal standpoint. But the roughly 22,000 women who were diagnosed with ovarian cancer last year, according to the National Cancer ...
Read More

Category: business news corporate lifestyle economy markets opinion

Suggested

13 hours ago, 16:59
@BusinessDaily - By: James Ngunjiri
Medical claims raise payout by Sh1bn

Claims in the medical, motor private and motor commercial segments of general insurance rose nearly Sh1 billion to raise overall claims insurers incurred 2.03 per cent during the second quarter. ...

Category: business news
12 hours ago, 18:14
@BusinessDaily - By: Lynet Igadwah
Uhuru, Ruto foreign travel spend falls 69pc

President Uhuru Kenyatta and his deputy William Ruto cut their foreign travel expenditure by 69 per cent or Sh223.3 million in the year to June as pressure piles on top government officials to ...

Category: business economy news
12 hours ago, 17:53
@BusinessDaily - By: Patrick Alushula
Kenya Power drops after profit warning

Kenya Power’s share plunged by 7.95 per cent in Monday’s trading at the Nairobi Securities Exchange (NSE) to close at Sh4.05 as investors factored in a profit warning. ...

Category: business economy news
12 hours ago, 17:56
@BusinessDaily - By: Constant Munda
Ngong wind firm gets Sh23.5bn loans insurance guarantee

Developers of the 100-megawatt Kipeto Wind Power Farm will tap emergency funds from African Trade Insurance Agency (ATI) to service a Sh23.53 billion loan. ...

Category: business economy news
12 hours ago, 17:45
@BusinessDaily - By: Doreen Wainainah
Airtel, Telkom join Safaricom with excise tax on mobile fees

Telco firms Airtel and Telkom Kenya have raised their call and messaging rates by 30 cents and 10 cents respectively. ...

Category: business economy news
12 hours ago, 17:47
@BusinessDaily - By: Doreen Wainainah
Hoteliers mourn deaths of Sarova founder, family

Kenyan hoteliers and the Vohra family were Monday still coming to terms with the tragic loss of Mohinder Singh Vohra (MS) and four family members in a road accident. ...

Category: business markets news corporate
Our App